Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.

Penile prostheses safe, well-accepted

21 May 2018
Sexual health in men – supplements vs medication

In men with severe erectile dysfunction (ED), primary (PPP) or secondary (SPP) penile prosthesis implantation is safe and well-accepted by the patients and their partners, a recent study has found.

Over a median follow-up period of 24.5 months, the median score on the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) was 86.4 points, indicating high overall satisfaction. Scores were comparable between patients who received PPP and SPP (87.5 vs 56.8 points; p=0.267).

The partners’ median EDITS scores also suggested high overall satisfaction with the intervention (66.7 points). There was no significant difference in the scores of partners in the PPP and SPP group (66.7 vs 33.3 points; p=0.24).

At a median follow-up of 26 months, 88.4 percent of the prostheses were still functional. This proportion was significantly higher in the PPP vs SPP group (94.4 percent vs 57.1 percent; p=0.024). The overall mean prosthesis survival was 63 months and was comparable between the two groups (67.0 months in the PPP group vs 55.5 months in the SPP group; p=0.169).

The findings of the present study support the use of penile prosthesis as an effective option for severe ED patients who do not respond to less invasive treatments, researchers said.

Researchers performed a retrospective study of 51 patients with severe ED (median age 61 years), of whom 41 received PPP and 10 received SPP. All SPP implants were placed following failure of PPP. The most common causes of ED were radical prostatectomy (27.5 percent) and diabetes (21.6 percent).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.